MedPath

GLAUKOS CORP.

GLAUKOS CORP. logo
🇺🇸United States
Ownership
Public
Established
1998-01-01
Employees
907
Market Cap
$7.4B
Website
http://www.glaukos.com

iStent Inject New Enrollment Post-Approval Study

Not Applicable
Active, not recruiting
Conditions
Glaucoma
Glaucoma, Open-Angle
Interventions
Device: iStent Inject Implantation
First Posted Date
2020-11-12
Last Posted Date
2024-02-23
Lead Sponsor
Glaukos Corporation
Target Recruit Count
358
Registration Number
NCT04624698
Locations
🇺🇸

Eye Doctors of Arizona, PLLC, Phoenix, Arizona, United States

🇺🇸

Wolstan and Goldberg Eye Associates, Torrance, California, United States

🇺🇸

Glaucoma Associates of Texas, Dallas, Texas, United States

iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study

Conditions
Glaucoma, Open-Angle
First Posted Date
2020-11-12
Last Posted Date
2021-10-20
Lead Sponsor
Glaukos Corporation
Target Recruit Count
475
Registration Number
NCT04624685
Locations
🇺🇸

Arizona Advanced Eye Research Institute, Glendale, Arizona, United States

🇺🇸

Vold Vision, PLLC, Fayetteville, Arkansas, United States

🇺🇸

North Bath Eye Associates, Inc., Santa Rosa, California, United States

and more 21 locations

Study of Exchange of Travoprost Intraocular Implant

Phase 2
Completed
Conditions
Open Angle Glaucoma
Interventions
First Posted Date
2020-11-04
Last Posted Date
2023-09-26
Lead Sponsor
Glaukos Corporation
Target Recruit Count
33
Registration Number
NCT04615403
Locations
🇺🇸

Inland Eye Specialists, Hemet, California, United States

🇺🇸

North Bath Eye Associates, Inc., Petaluma, California, United States

🇺🇸

Eye Center of northern Colorado, PC, Fort Collins, Colorado, United States

and more 11 locations

Clinical Study Comparing Two Models of a Travoprost Intraocular Implant

Phase 3
Completed
Conditions
Glaucoma, Open-Angle
Ocular Hypertension
Interventions
Combination Product: G2-TR intraocular implant containing travoprost
Drug: Sham surgery + active-comparator eye drops
First Posted Date
2019-03-08
Last Posted Date
2024-11-28
Lead Sponsor
Glaukos Corporation
Target Recruit Count
560
Registration Number
NCT03868124
Locations
🇺🇸

Center for Sight, Las Vegas, Nevada, United States

Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma

Not Applicable
Conditions
Glaucoma
Interventions
Device: Model iS3 three-stent trabecular micro-bypass system
First Posted Date
2018-08-21
Last Posted Date
2021-04-23
Lead Sponsor
Glaukos Corporation
Target Recruit Count
65
Registration Number
NCT03639870
Locations
🇺🇸

Glaucoma Associates of Tx, Dallas, Texas, United States

Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Phase 3
Completed
Conditions
Glaucoma, Open-Angle
Ocular Hypertension
Interventions
Combination Product: G2-TR intraocular implant containing travoprost
Drug: Sham surgery + active-comparator eye drops
First Posted Date
2018-05-09
Last Posted Date
2024-11-29
Lead Sponsor
Glaukos Corporation
Target Recruit Count
590
Registration Number
NCT03519386
Locations
🇺🇸

Vance Thompson Vision, Sioux Falls, South Dakota, United States

iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

Not Applicable
Terminated
Conditions
Primary Open Angle Glaucoma (POAG)
Interventions
Device: iStent inject surgery
First Posted Date
2018-03-27
Last Posted Date
2022-09-09
Lead Sponsor
Glaukos Corporation
Target Recruit Count
6
Registration Number
NCT03478293
Locations
🇧🇷

Department of Ophthalmology - UNIFESP/ Hospital São Paulo, São Paulo, Brazil

Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus

Phase 3
Completed
Conditions
Progressive Keratoconus
Interventions
Drug: Test Article A
Drug: Placebo
Drug: Test Article B
Device: KXL medical device system
First Posted Date
2018-02-22
Last Posted Date
2024-01-30
Lead Sponsor
Glaukos Corporation
Target Recruit Count
201
Registration Number
NCT03442751
Locations
🇺🇸

Ophthalmic Consultants of Boston, Waltham, Massachusetts, United States

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
Conditions
Corneal Ectasia
Interventions
Combination Product: Corneal Collagen Cross-linking
First Posted Date
2017-10-24
Last Posted Date
2024-02-23
Lead Sponsor
Glaukos Corporation
Target Recruit Count
200
Registration Number
NCT03319082
Locations
🇺🇸

Stanford University School of Medicine, Palo Alto, California, United States

🇺🇸

Chu Vision Institute, P.A., Bloomington, Minnesota, United States

🇺🇸

Vance Thompson Vision - MT, Bozeman, Montana, United States

and more 8 locations

Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent Supra

Not Applicable
Completed
Conditions
Glaucoma, Open-Angle
Interventions
Device: Cataract surgery plus one iStent and one iStent Supra implanted
First Posted Date
2017-08-21
Last Posted Date
2022-09-09
Lead Sponsor
Glaukos Corporation
Target Recruit Count
15
Registration Number
NCT03255785
Locations
🇦🇲

Glaukos Investigator Sites, Yerevan, Armenia

© Copyright 2025. All Rights Reserved by MedPath